|
|
| Maladies Cardiovasculaires > Etude de marché sectorielle |
| Disease and Therapy Review: Stroke |
|
|
|
|
€ 720,00 |
Editeur
: |
Timely Data Resources |
Langue
: |
Anglais |
Date de publication : |
Septembre 2006 |
Taille du document : |
7 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
|
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
Cardiac Pacemakers
237 pages | Octobre 2005 |
This report analyzes the worldwide markets for Cardiac Pacemakers in Millions of US$.
The major product segments analyzed are Implantable Pacemakers, and External Pacemakers.
The sub product seg |
3 091,00 €
|
| |
| |
Cardiac Defibrillators
257 pages | Août 2005 |
This report analyzes the worldwide markets for Cardiac Defibrillators in Units.
The specific product segments analyzed are Implantable/Internal Cardiac Defibrillator, and External Defibrillator.
2 699,00 €
|
|
| |
| |
Event Analysis and Response Service: Cox-2s - Cox-2 Crisis Dents Big Pharma Confidence
95 pages | Juin 2005 |
IntroductionOn 30th September 2004, Merck withdrew its blockbuster drug Vioxx from the global market after trial data reinforced the suspicion that it increased the risk of cardiovascular events.
V |
9 120,00 €
|
| |
| |
The Cardiovascular Market Outlook to 2010
174 pages | Octobre 2005 |
The range of conditions within cardiovascular disease is wide, although the basic etiology of cardiovascular disease is generally well understood the focus on treatment in cardiovascular disease is tw |
2 443,75 €
|
| |
| |
Strategies in Nutraceuticals: Functional Food and Drinks
163 pages | Janvier 1999 |
The nutraceuticals market has been an important area of development for food, drinks, ingredients and pharmaceutical companies since the beginning of the 1990s.
Products such as Red Bull, Nut |
795,00 €
|
| |
| |
Innovation in Functional Food and Drinks: Growth opportunities from new nutraceutical ingredients
178 pages | Novembre 2005 |
Cardiovascular epidemiology data shows there will be increasing opportunities for cholesterol lowering products and functional health products with heart health benefits, particularly in the UK, Germa |
1 623,50 €
|
| |
| |
The Cardiovascular Outlook 2000
161 pages | Septembre 2000 |
In 1999, cardiovascular drugs represented the largest single segment of the global pharmaceutical industry by value.
Estimated sales of $69.6bn represented growth of 8.2% over 1998 levels.
|
955,00 €
|
| |
| |
Latest Developments In Insulin Delivery Technology
10 pages | Novembre 2002 |
Insulin dependent diabetics used to depend on syringes as the mode of delivery of insulin.
Now, insulin pens, pumps and jet injectors are also being used.
But none of these existing technologies |
200,00 €
|
| |
| |
Diabetes, Metabolic Syndrome and Cardiovascular Disease Markets
161 pages | Octobre 2005 |
This report describes the specific market segment of the pharmaceutical market for diabetes and two of its related diseases, metabolic syndrome and cardiovascular disease.
It begins with a textbook |
2 800,00 €
|
| |
| |
Prevention of Coronary Heart Disease - Promoting Healthy Lifestyles
39 pages | Juillet 2005 |
IntroductionCoronary heart disease is the most common cause of death in Europe and the US, at a rate of one in five.
However, the majority of coronary events can be prevented by education about ris |
1 520,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
| Disease and Therapy Review: Stroke |
|
|
The Stroke Disease and Therapy Review provides incidence and prevalence numbers and percentages for major countries worldwide, and an overview of treatments. General information is provided on the value of the US and worldwide stroke markets.
Additional Information
Disease and Therapy Reviews were developed to provide a basic understanding of the key facts about a disease and market in a quick, easy-to-read format. These reports are prepared by the senior market research team of Timely Data Resources. Each Disease and Therapy Review provides a concise analysis of the most important information about a particular disease, its treatment, and the market opportunities. Reports begin with an overview of the condition, and also contain tables that summarize the available worldwide incidence and prevalence data for the condition, a review of current diagnosis strategies and treatment options, general information about the market size, and information about important market trends. The data contained in these reports comes from key industry secondary data sources, such as the Timely Data Resources Incidence and Prevalence Database, and Lange's Current Medical Diagnosis and Treatment. This information is supplemented by reviews of analyst reports, company reports, and medical websites. Sources and references are provided.
|
|
I. Overview
II. Incidence and Prevalence
Incidence Table: (US, Canada, UK, France, Germany, Italy, Japan, China, Worldwide)
Prevalence Table: (US, Canada, UK, Japan, China, India, Worldwide)
III. TREATMENT
IV. DOSING
V. MARKET SIZE
VI. COMMENTS
VII. References/Resources
|
|
|
PPLSEN
|
|
|
|
|
